Research progress of neural stem cell transplantation in the treatment of severe cerebral palsy in child Reviewer: ZHOU Juhua, FANG Suzhen, ZHOU Xizhong, Reviser: LI Hong (Department of Pediatrics, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, Guangdong, China)
[1] Dabney KW，Miller F. Current approaches in cerebral palsy，a focus on gait problems： editorial comment [J]. Clin Orthop Relat Res，2012，470(5)：1247-1248. [2] 沈晓明，王卫平. 儿科学 [M]. 7版. 北京：人民卫生出版社，2008：373. [3] Luan Z，Liu W，Qu S，et al. Effects of neural progenitor cell transplantation in children with severe cerebral palsy [J]. Cell Transplant，2012，21（Suppl1）：S91-S98. [4] Blair E. Epidemiology of the cerebral palsies [J]. Orthop Clin North Am，2010，41(4)：441-455. [5] Zheng XR，Zhang SS，Yin F，et al. Neuroprotection of VEGF-expression neural stem cells in neonatal cerebral palsy rats [J]. Behav Brain Res，2012，230(1)：108-115. [6] Azari H，Rahman M，Sharififar S，et al. Isolation and expansion of the adult mouse neural stem cells using the neurosphere assay [J]. J Vis Exp，2010，(45)：2393. [7] Deleyrolle LP，Reynolds BA. Isolation，expansion，and differentiation of adult Mammalian neural stem and progenitor cells using the neurosphere assay [J]. Methods Mol Biol，2009，549：91-101. [8] Azari H，Osborne GW，Yasuda T，et al. Purification of immature neuronal cells from neural stem cell progeny [J]. PLoS One，2011，6(6)：e20941. [9] Goldman SA，Windrem MS. Cell replacement therapy in neurological disease [J]. Philos Trans R Soc Lond B Biol Sci，2006，361(1473)：1463-1475. [10] Louis SA，Mak CK，Reynolds BA. Methods to culture，differentiate，and characterize neural stem cells from the adult and embryonic mouse central nervous system [J]. Methods Mol Biol，2013，946：479-506. [11] Xu N，Papagiannakopoulos T，Pan G，et al. MicroRNA-145 regulates OCT4，SOX2，and KLF4 and represses pluripotency in human embryonic stem cells [J]. Cell，2009，137(4)：647-658. [12] Yue F，Chen B，Wu D，et al. Biological properties of neural progenitor cells isolated from the hippocampus of adult cynomolgus monkeys [J]. Chin Med J (Engl)，2006，119(2)：110-116. [13] Fansa H，Keilhoff G. Comparison of different biogenic matrices see-ded with cultured Schwann cells for bridging peripheral nerve defects[J]. Neurol Res，2004，26(2)：167-173. [14] Bliss T，Guzman R，Daadi M，et al. Cell transplantation therapy for stroke [J]. Stroke，2007，38(Suppl 2)：817-826. [15] Rosenblum S，Wang N，Smith TN，et al. Timing of intra-arterial neural stem cell transplantation after hypoxia-ischemia influences cell engraftment，survival，and differentiation [J]. Stroke，2012，43(6)： 1624-1631. [16] Daadi MM，Davis AS，Arac A，et al. Human neural stem cell grafts modify microglial response and enhance axonal sprouting in neonatal hypoxic-ischemic brain injury [J]. Stroke，2010，41(3)：516-523. [17] Madhavan L，Ourednik V，Ourednik J. Neural stem/progenitor cells initiate the formation of cellular networks that provide neuroprotection by growth factor-modulated antioxidant expression [J]. Stem Cells，2008，26(1)：254-265. [18] Tongiorgi E. Activity-dependent expression of brain-derived neurotrophic factor in dendrites：facts and open questions [J]. Neurosci Res，2008，61(4)：335-346. [19] Lee JS，Hong JM，Moon GJ，et al. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke [J]. Stem Cells，2010，28(6)：1099-1106. [20] Li Y，Chopp M. Marrow stromal cell transplantation in stroke and traumatic brain injury [J]. Neurosci Lett，2009，456(3)：120-123. [21] Chen J，Zhang ZG，Li Y，et al. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats [J]. Circ Res，2003，92(6)： 692-699. [22] Amit M，Chebath J，Margulets V，et al. Suspension culture of undiffe-rentiated human embryonic and induced pluripotent stem cells [J]. Stem Cell Rev，2010，6(2)：248-259. [23] McDonald JW，Liu XZ，Qu Y，et al. Transplanted embryonic stem cells survive，differentiate and promote recovery in injured rat spinal cord [J]. Nat Med，1999，5(12)：1410-1412. [24] van Velthoven CT，Kavelaars A，van Bel F，et al. Nasal administration of stem cells： a promising novel route to treat neonatal ischemic brain damage [J]. Pediatr Res，2010，68(5)：419-422. [25] Webber DJ，van Blitterswijk M，Chandran S. Neuroprotective effect of oligodendrocyte precursor cell transplantation in a long-term model of periventricular leukomalacia [J]. Am J Pathol，2009，175(6)： 2332-2342. [26] 栾佐，屈素清，刘卫鹏，等. 人神经干细胞移植治疗重度视觉障碍脑瘫患儿的临床观察 [J]. 中国康复理论与实践，2007，13(12)：1103-1105. [27] Chandran S，Caldwell M，Allen N. Introduction： stem cells and brain repair [J]. Philos Trans R Soc Lond B Biol Sci，2008，363(1489)：5-7. [28] Kim S，Honmou O，Kato K，et al. Neural differentiation potential of peripheral blood and bone marrow-derived precursor cells [J]. Brain Res，2006，1123(1)：27-33. [29] Wei L，Fraser JL，Lu ZY，et al. Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats [J]. Neurobiol Dis，2012，46(3)：635-645. [30] Li M，Yu A，Zhang F，et al. Treatment of one case of cerebral palsy combined with posterior visual pathway injury using autologous bone marrow mesenchymal stem cells [J]. J Transl Med，2012，10：100. [31] Purandare C，Shitole DG，Belle V，et al. Therapeutic potential of auto-logous stem cell transplantation for cerebral palsy [J]. Case Rep Transplant，2012，2012：825289. [32] Lu D，Chen B，Liang Z，et al. Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer： a double-blind，randomized，controlled trial [J]. Diabetes Res Clin Pract，2011，92(1)：26-36. [33] 杜侃，栾佐，屈素清，等. 骨髓间充质干细胞移植治疗小儿重度脑性瘫痪的疗效观察 [J]. 临床儿科杂志，2011，29(1)：55-58. [34] Sun J，Allison J，McLaughlin C，et al. Differences in quality between privately and publicly banked umbilical cord blood units： a pilot study of autologous cord blood infusion in children with acquired neurologic disorders [J]. Transfusion，2010，50(9)：1980-1987. [35] Lee YH，Choi KV，Moon JH，et al. Safety and feasibility of counte-ring neurological impairment by intravenous administration of autologous cord blood in cerebral palsy [J]. J Transl Med，2012，10： 58. [36] 杨华强，张荣环，杜玲，等. 脐带间充质干细胞移植对脑瘫患儿运动功能的影响 [J]. 现代生物医学进展，2012，12(2)：250-252. [37] Jensen A，Hamelmann E. First autologous cell therapy of cerebral palsy caused by hypoxic-ischemic brain damage in a child after cardiac arrest-individual treatment with cord blood [J]. Case Rep Transplant，2013，2013： 951827. [38] International Association of Neurorestoratology. Beijing Declaration of International Association of Neurorestoratology (IANR). Cell Transplant，2009，18：487. [39] Tian ZM，Chen T，Zhong N，et al. Clinical study of transplantation of neural stem cells in therapy of inherited cerebellar atrophy [J]. Beijing Da Xue Xue Bao，2009，41(4)：456-458. [40] 吴景文，贾丹兵，曲超法，等. 干细胞移植治疗小儿脑瘫的临床疗效：40例报告 [J]. 中华神经外科疾病研究杂志，2011，10(5)： 424-427. [41] Shimazu K，Zhao M，Sakata K，et al. NT-3 facilitates hippocampal plasticity and learning and memory by regulating neurogenesis [J].Learn Mem，2006，13(3)：307-315. [42] Wang LM，Wang HY，Yang ZJ，et al. Combined transplantation of neurotrophin-3 and neural stem cells in treatment of hypoxic-ischemic brain injury in rats[J]. Zhonghua Er Ke Za Zhi，2007，45(3)： 212-216. [43] 栾 佐.新生动物及其缺血性脑损伤神经干细胞移植的研究现状[J].中华儿科杂志，2004，42(4)：305-307. (收稿日期：2013-07-01)
